Anelixis Therapeutics to Provide Pipeline of Clinical Candidates for ALS

First Page		Document Content
Date: 2014-02-10 09:02:54 Amyotrophic lateral sclerosis Motor neurone disease Pharmaceutical industry James Heywood ALS Association Rare diseases Health ALS Therapy Development Institute		Anelixis Therapeutics to Provide Pipeline of Clinical Candidates for ALS Add to Reading List Source URL: www.als.net Download Document from Source Website File Size: 364,03 KB Share Document on Facebook

	Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis DocID: 1qMIa - View Document
	Subject: Call for Letters of Intent to Target ALS Foundation for Young Investigator-led Collaborative Projects (YICPs) Dear Investigator, Target ALS Foundation is an independent non-profit 501(c)(3) foundation working DocID: 1qwy8 - View Document
	Postdoc position in environmental causes of DocID: 1qdo8 - View Document
	Vertrauensbildende Massnahmen ALS Diplomatie On start-up, between Vertrauensbildende Massnahmen ALS Diplomatie taking online partners by energy to your periods, options will be required too. The greenery is able also to DocID: 1pZjN - View Document
	READTHEORY ® TEACHING STUDENTS TO READ AND THINK CRITICALLY DocID: 1p6lY - View Document